Imprinting of the specific molecular image of a given protein antigen into immunological memory is one of the hallmarks of immunity. A later contact with a related, but different antigen should not trigger the memory response (because the produced antibodies would not be effective). The preferential expansion of cross-reactive antibodies, or T-lymphocytes for that matter,…
Clinical Immunology Communications Template
Write in a clean editor, then format for Clinical Immunology Communications in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Clinical Immunology Communications format
Clinical Immunology Communications is a peer-reviewed journal published by Elsevier, covering SARS-CoV-2 and COVID-19 Research, Immunodeficiency and Autoimmune Disorders, COVID-19 Clinical Research Studies.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Clinical Immunology Communications 12 (2023) 45–58.
Formats any DOI in Clinical Immunology Communications style. No sign-up. |
| Publishes research in | SARS-CoV-2 and COVID-19 Research Immunodeficiency and Autoimmune Disorders COVID-19 Clinical Research Studies Immune Cell Function and Interaction Cancer Immunotherapy and Biomarkers |
| ISSN | 2772-6134 |
| Citation impact (2-yr) | 0.97 |
| h-index | 10 |
| i10-index | 11 |
| Total citations | 375 |
| Article processing charge | $1,750 |
| Open access | Yes |
| Top institutions publishing here | Umm al-Qura University |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Clinical Immunology Communications per year
Citation impact of Clinical Immunology Communications by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Clinical Immunology Communications
Breast cancer has a heavy toll on the world's health, both in terms of morbidity and death. For women aged 35 to 54, it is the primary cause of mortality. In addition, over the preceding 2 decades, the mortality rate has not decreased noticeably. Early diagnosis and detection are still essential for enhancing patient outcomes…
SARS-CoV-2 causes Coronavirus Disease 2019 (COVID-19), an infectious condition that can present none or one or more of these symptoms: fever, cough, headache, sore throat, loss of taste and smell, aches, fatigue and musculoskeletal pain. For the prevention of COVID-19, there are vaccines available including those developed by Pfizer, Moderna, Sinovac, Janssen, and AstraZeneca. Recent…
Evidence suggests vitamin D3 resistance with gene polymorphisms related to its metabolism to have a potential role in the patho-prognosis of psoriasis. We report 6 cases of psoriasis treated with daily oral Vitamin D3 (25 hydroxy cholecalciferol) in doses ranging from 30,000 IU to 60,000 IU over a period of 2 to 6 months and…
Vitiligo is an autoimmune disorder, which is characterized by the chronic loss of melanocytes and subsequent lack of melanin from the skin or hair or both. The resultant depigmentation state of the skin causing irregular white patches deteriorates the vitiligo patients’ quality of life by major stigmatizing psychological impact. Despite tremendous studies for the past…